Histone deacetylase (HDAC) inhibitors targeting HDAC3 and HDAC1 ameliorate polyglutamine-elicited phenotypes in model systems of Huntington's disease-Reference-Cited by-同舟云学术

Histone deacetylase (HDAC) inhibitors targeting HDAC3 and HDAC1 ameliorate polyglutamine-elicited phenotypes in model systems of Huntington's disease

Published:2012-05 Issue:2 Volume:46 Page:351-361
ISSN:0969-9961
Container-title:Neurobiology of Disease
language:en
Short-container-title:Neurobiology of Disease

Author:

Jia Haiqun,Pallos Judit,Jacques Vincent,Lau Alice,Tang Bin,Cooper Andrew,Syed Adeela,Purcell Judith,Chen Yi,Sharma Shefali,Sangrey Gavin R.,Darnell Shayna B.,Plasterer Heather,Sadri-Vakili Ghazaleh,Gottesfeld Joel M.,Thompson Leslie M.,Rusche James R.,Marsh J. Lawrence,Thomas Elizabeth A.

Funder

NIH

Repligen Corporation

Publisher

Elsevier BV

Subject

Neurology

Reference42 articles.

1. Epigenetic targets of HDAC inhibition in neurodegenerative and psychiatric disorders;Abel;Curr. Opin. Pharmacol.,2008

2. Epigenetics and airways disease;Adcock;Respir. Res.,2006

3. Selective toxicity by HDAC3 in neurons: regulation by Akt and GSK3beta;Bardai;J. Neurosci.,2011

4. The Sir2 family of protein deacetylases;Blander;Annu. Rev. Biochem.,2004

5. Chemical phylogenetics of histone deacetylases;Bradner;Nat. Chem. Biol.,2011

Cited by 152 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of histone deacetylases and their inhibitors in neurological diseases;Pharmacological Research;2024-09

2. Discovery of Novel HDAC3 Inhibitors with PD-L1 Downregulating/Degrading and Antitumor Immune Effects;Journal of Medicinal Chemistry;2024-07-20

3. The Histone Deacetylase Family: Structural Features and Application of Combined Computational Methods;Pharmaceuticals;2024-05-10

4. Vitamin A deficiency suppresses CEACAM1 to impair colonic epithelial barrier function via downregulating microbial-derived short-chain fatty acids;Genes & Diseases;2024-03

5. Unlocking the Epigenetic Symphony: Histone Acetylation’s Impact on Neurobehavioral Change in Neurodegenerative Disorders;Epigenomics;2024-02-07